Research Paper Volume 16, Issue 11 pp 10074—10107
Immunotherapy, prognostic, and tumor biomarker based on pancancer analysis, SMARCD3
Figure 2. KM survival curves based on overall survival in 7 cancers. (A) COAD; (B) HNSC; (C) KIRC; (D) LUAD; (E) THCA; (F) UCFC; (G) UVM.